Lab Home | Phone | Search
Center for Nonlinear Studies  Center for Nonlinear Studies
 Home 
 People 
 Current 
 Executive Committee 
 Postdocs 
 Visitors 
 Students 
 Research 
 Publications 
 Conferences 
 Workshops 
 Sponsorship 
 Talks 
 Seminars 
 Postdoc Seminars Archive 
 Quantum Lunch 
 Quantum Lunch Archive 
 P/T Colloquia 
 Archive 
 Ulam Scholar 
 
 Postdoc Nominations 
 Student Requests 
 Student Program 
 Visitor Requests 
 Description 
 Past Visitors 
 Services 
 General 
 
 History of CNLS 
 
 Maps, Directions 
 CNLS Office 
 T-Division 
 LANL 
 
Friday, November 12, 2010
11:00 AM - 12:30 PM
CNLS Conference Room (TA-3, Bldg 1690)

Seminar

Effects of Aromatic Substitutions on Halogen Bonds, with Applications to Protein-Ligand Binding

Kevin Riley
University of Puerto Rico, Rio Peidras

In the past several years, halogen bonds have been shown to be relevant in crystal engineering and biomedical applications. One of the reasons for the utility of these types of noncovalent interactions in the development of, for example, pharmaceutical ligands is that their strengths and geometric properties are very tunable. That is, substitution of atoms or chemical groups in the vicinity of a halogen can have a very strong effect on the strength of the halogen bond. In this study we investigate halogen-bonding interactions involving aromatically-bound halogens (Cl, Br, and I) and a carbonyl oxygen. The properties of these halogen bonds are modulated by substitution of aromatic hydrogens with fluorines, which are very electronegative. It is found that these types of substitutions have dramatic effects on the strengths of the halogen bonds, leading to interactions that can be up to 100% stronger. Very good correlations are obtained between the interaction energies and the magnitudes of the positive electrostatic potentials (σ-holes) on the halogens. We also investigate interactions of several modified tetrabromobenzoimidazole derivatives with the protein kinase CK2, which promotes cell survival and is involved in the survival of tumor cells. Tetrabromobenzoimidazole is an inhibitor of CK2 whose mode of interaction involves a strong halogen bond.  

Host: Mike Wall, mewall@lanl.gov